University of Edinburgh: Obesity Drug Heart Benefits Not Just Due to Weight Loss
September 24, 2026
September 24, 2026
EDINBURGH, Scotland, Sept. 24 (TNSjou) -- The University of Edinburgh issued the following news:
* * *
Obesity drug heart benefits not just due to weight loss
The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone, a study shows.
Researchers examined known risk factors for heart disease, such as body weight and waist circumference, in p . . .
* * *
Obesity drug heart benefits not just due to weight loss
The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone, a study shows.
Researchers examined known risk factors for heart disease, such as body weight and waist circumference, in p . . .
